DRKS00013124
Completed
未知
A randomized controlled trial for investigating a novel integrated care concept (NICC) for patients suffering from chronic cardiovascular disease: CardioCare MV - CardioCare MV
niversitätsmedizin Rostock0 sites964 target enrollmentOctober 5, 2017
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- I50
- Sponsor
- niversitätsmedizin Rostock
- Enrollment
- 964
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Heart failure (I50, NYHA II\-IV) or atrial fibrillation (I48, EHRA II\-IV) or resistant hypertension (I10\-15, \= 3 antihypertensive medicines from different drug classes, SBP \> 140 /90mmHg or \= 4 antihypertensives irrespective of the blood pressure, with at least one drug being a diuretic).
- •2\. Member of health insurance company AOK Nordost or Techniker Krankenkasse (TK).
- •3\. Inscription to integrated care contract with the health insurance company.
- •4\. Residence in Mecklenburg\-Vorpommern.
- •5\. Age \= 18 years.
- •6\. Written informed consent.
Exclusion Criteria
- •1\. Pregnancy, suspected pregnancy or breast\-feeding period.
- •2\. Participation in another clinical trial up to 30 days before inclusion in this trial.
- •3\. Cognitive deficits: patients need to be able to read and understand German language as presented on a tablet.
- •4\. Chronic kidney disease requiring dialysis or creatinine clearance \< 15 ml/min.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
A randomised, controlled trial to investigate the effect of a four/six week intensified pharmacological treatment for schizophrenia, major depressive disorder and bipolar depression compared to treatment as usual in subjects who had a first-time treatment failure on their first-line treatment.Schizophrenia, schizoaffective disorder, schizophreniform disorder, major depressive disorder or bipolar disorder type I and II (currently in a depressive episode)MedDRA version: 20.0Level: HLTClassification code: 10039620Term: Schizoaffective and schizophreniform disorders Class: 10037175MedDRA version: 21.1Level: LLTClassification code: 10081270Term: Major depressive disorder Class: 10037175MedDRA version: 20.0Level: PTClassification code: 10039626Term: Schizophrenia Class: 100000004873MedDRA version: 21.1Level: LLTClassification code: 10004936Term: Bipolar depression Class: 10037175Therapeutic area: Psychiatry and Psychology [F] - Mental Disorders [F03]CTIS2022-502185-24-00niversity Medical Center Utrecht1,254
Active, not recruiting
Phase 1
A randomised, controlled trial to investigate the effect of a six-week intensified pharmacological treatment for bipolar depression compared to treatment as usual in subjects who had a first-time treatment failure on their first-line treatment.Bipolar depressionMedDRA version: 21.1Level: LLTClassification code: 10004936Term: Bipolar depression Class: 10037175Therapeutic area: Psychiatry and Psychology [F] - Mental Disorders [F03]CTIS2023-506605-19-00niversitair Medisch Centrum Utrecht423
Completed
Phase 4
A study to investigate the real-life use of the Vannair SMART regime in adult asthma (the SMART study).AsthmaRespiratory - AsthmaACTRN12610000515099Medical Research Institute of New Zealand300
Active, not recruiting
Phase 1
A randomised, controlled trial to investigate the effect of a six-week intensified pharmacological treatment for major depressive disorder compared to treatment as usual in subjects who had a first-time treatment failure on their first-line treatment.Major depressive disorderMedDRA version: 21.1Level: LLTClassification code: 10081270Term: Major depressive disorder Class: 10037175Therapeutic area: Psychiatry and Psychology [F] - Mental Disorders [F03]CTIS2023-506617-21-00niversitair Medisch Centrum Utrecht418
Active, not recruiting
Phase 4
A clinical study to investigate whether third-line treatments work better as a second-line treatment for people diagnosed with schizophreniaSchizophrenia, schizoaffective disorder or schizophreniform disorderMental and Behavioural DisordersISRCTN83479057niversity Medical Center Utrecht418